Flagstar Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,826
| Closed | -$235K | – | 168 |
|
|
2023
Q2 | $235K | Sell |
2,826
-2,280
| -45% | -$190K | 0.09% | 145 |
|
|
2023
Q1 | $389K | Sell |
5,106
-402
| -7% | -$30.6K | 0.14% | 118 |
|
|
2022
Q4 | $457K | Sell |
5,508
-415
| -7% | -$34.4K | 0.16% | 106 |
|
|
2022
Q3 | $470K | Buy |
5,923
+1,903
| +47% | +$151K | 0.18% | 107 |
|
|
2022
Q2 | $298K | Buy |
4,020
+290
| +8% | +$21.5K | 0.11% | 125 |
|
|
2022
Q1 | $335K | Buy |
3,730
+1,327
| +55% | +$119K | 0.11% | 121 |
|
|
2021
Q4 | $269K | Sell |
2,403
-389
| -14% | -$43.5K | 0.08% | 124 |
|
|
2021
Q3 | $351K | Buy |
+2,792
| New | +$351K | 0.12% | 107 |
|